CAMP
CAMP4 THERAPEUTICS CORPORATION
NASDAQ: CAMP · HEALTHCARE · BIOTECHNOLOGY
$4.01
-6.09% today
Updated 2026-04-29
Market cap
$230.55M
P/E ratio
—
P/S ratio
65.91x
EPS (TTM)
$-2.65
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
CAMP4 THERAPEUTICS CORPORATION (CAMP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+4.7%
Last 4 quarters
Revenue YoY growth
-46.6%
Most recent quarter
EPS YoY growth
+70.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-9.3%
2026-03-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.23 | +16.4% | $4.75 | $4.31 | -9.3% |
| 2025-11-06 | $-0.55 | -16.5% | $4.16 | $4.25 | +2.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.27 | $-0.23 | +16.4% | $348000.00 | -46.6% |
| 2025-09-30 | $-0.47 | $-0.55 | -16.5% | $795000.00 | — |
| 2025-06-30 | $-0.67 | $-0.62 | +7.5% | $1.50M | — |
| 2025-03-31 | $-0.70 | $-0.62 | +11.4% | $858000.00 | — |
| 2024-12-31 | $-0.82 | $-0.77 | +6.5% | $652000.00 | — |
| 2024-09-30 | $-1.17 | $-24.19 | -1967.5% | — | — |
| 2024-06-30 | $0.00 | $-52.56 | — | — | — |
| 2023-09-30 | $0.03 | $-0.01 | -133.3% | $350000.00 | — |
| 2023-06-30 | $0.04 | $0.01 | -75.0% | $70.89M | — |
| 2022-06-30 | $-0.03 | $-0.02 | +33.3% | — | — |
| 2022-03-31 | $-0.03 | $-0.10 | -233.3% | — | — |
| 2021-09-30 | $0.08 | $-0.08 | -200.0% | — | — |
| 2021-06-30 | $0.06 | $0.08 | +33.3% | — | — |
| 2021-03-31 | $0.07 | $0.08 | +14.3% | — | — |
Frequently asked questions
Has CAMP4 THERAPEUTICS CORPORATION beaten earnings estimates?
CAMP4 THERAPEUTICS CORPORATION has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +4.7% over the last 4 quarters.
How does CAMP stock react to earnings?
CAMP stock has moved an average of -3.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is CAMP4 THERAPEUTICS CORPORATION's revenue growth rate?
CAMP4 THERAPEUTICS CORPORATION reported year-over-year revenue growth of -46.6% in its most recent quarter, with EPS growing +70.7% year-over-year.